Singular Genomics Systems (OMIC) IPO Opens 32% Higher

Today's IPO for Singular Genomics Systems, Inc. (NASDAQ: OMIC) opened for trading earlier at $29 after pricing 10,200,000 shares of its common stock at an initial public offering price of $22.00 per share. Shares have trended lower to $27.39 since the opening.

J.P. Morgan, Goldman Sachs & Co. LLC, BofA Securities and Cowen are acting as joint book-running managers for the offering. UBS Investment Bank is also acting as a book-running manager.

Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics’ products in development and Singular Genomics’ core product tenets: accuracy, speed, flexibility and scale. Singular Genomics’ first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution.

You May Also Be Interested In

• SpaceX Shares Indicated To Open At $155
• HTX Releases May Performance Report: TradFi Monthly Trading Volume Surpasses $1 Billion, While Multi-Front Progress Rebuilds Ecosystem Confidence
• Inspire Investing Screens SpaceX Negative, Citing Ownership of X Platform Documented for Child Sexual Exploitation